The pharmacological effect of Dagliflozin Tablets is to reduce blood glucose by inhibiting sodium-glucose co-transporter protein 2 expressed in renal proximal tubules, decreasing renal glucose reabsorption and increasing urinary glucose excretion. Dagliflozin tablets are a hypoglycemic drug that can be used to treat adult patients with type 2 diabetes to help improve blood sugar. It should be noted that this drug is contraindicated for those who are allergic to this drug as well as those with severe renal impairment, end-stage renal disease, and those who require dialysis. Adverse reactions such as hypotension, acute kidney injury, pyelonephritis, ketoacidosis may occur after taking this drug. Patients who need to use Dagliflozin Tablets for treatment are recommended to do so under the guidance of a doctor.